[Retracted] Liuwei Dihuang Pill Attenuates Diabetic Nephropathy by Inhibiting Renal Fibrosis via TGF-β/Smad2/3 Pathway

Figure 3

The LDP therapy reduced renal fibrosis in DN by blocking the expression of TGF-β RI, TGF-β RII (a), phosphorylated Smad2 (b), and phosphorylated Smad3 (c).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)